Tests for latent tuberculosis in people with ESRD: A systematic review

American Journal of Kidney Diseases

Volumn 61, Issue 1, 2013, Pages 33-43

  Rogerson, Thomas E ^a,b   Chen, Sharon ^c   Kok, Jen ^c   Hayen, Andrew ^b   Craig, Jonathan C ^a,b   Sud, Kamal ^c   Kable, Kathy ^c   Webster, Angela C ^a,b,c  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

Author keywords

dialysis; end stage kidney disease; Latent tuberculosis; QuantiFERON; systematic review; T SPOT.TB; transplantation; tuberculin skin test

Indexed keywords

GAMMA INTERFERON;

CHRONIC KIDNEY DISEASE; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; HUMAN; IMMUNE FUNCTION TEST; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; LATENT TUBERCULOSIS; PREVALENCE; RENAL REPLACEMENT THERAPY; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; TUBERCULIN TEST;

EID: 84871254495     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2012.07.019     Document Type: Article

References (67)

1. U. Mack, G.B. Migliori, M. Sester LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement Eur Respir J 33 5 2009 956 973
2. K. Cengiz Increased incidence of tuberculosis in patients undergoing hemodialysis Nephron 73 3 1996 421 424 (Pubitemid 26229696)
3. M.M. Hussein, J.M. Mooij, H. Roujouleh Tuberculosis and chronic renal disease Semin Dial 16 1 2003 38 44 (Pubitemid 37356765)
4. C.C. Dobler, S.P. McDonald, G.B. Marks Risk of tuberculosis in dialysis patients: a nationwide cohort study PLoS ONE 6 12 2011 e29563
5. R.M. Jasmer, P. Nahid, P.C. Hopewell Clinical practice Latent tuberculosis infection N Engl J Med 347 23 2002 1860 1866 (Pubitemid 35417778)
6. H.M. Blumberg, W.J. Burman, R.E. Chaisson American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis Am J Respir Crit Care Med 167 4 2003 603 662
7. M. Sousa, A. Pozniak, M. Boffito Pharmacokinetics and pharmacodynamics of drug interactions involving rifampicin, rifabutin and antimalarial drugs J Antimicrob Chemother 62 5 2008 872 878
8. M. Niemi, J.T. Backman, M.F. Fromm, P.J. Neuvonen, K.T. Kivisto Pharmacokinetic interactions with rifampicin: clinical relevance Clin Pharmacokinet 42 9 2003 819 850 (Pubitemid 36995083)
9. N.P. Thompson, M.E. Caplin, M.I. Hamilton Anti-tuberculosis medication and the liver: dangers and recommendations in management Eur Respir J 8 8 1995 1384 1388
10. M. Sester, U. Sester, P. Clauer Tuberculin skin testing underestimates a high prevalence of latent tuberculosis infection in hemodialysis patients Kidney Int 65 5 2004 1826 1834 (Pubitemid 38591032)
11. L. Segall, A. Covic Diagnosis of tuberculosis in dialysis patients: current strategy Clin J Am Soc Nephrol 5 6 2010 1114 1122
12. C.M. Denkinger, K. Dheda, M. Pai Guidelines on interferon-gamma release assays for tuberculosis infection: concordance, discordance or confusion? Clin Microbiol Infect 17 6 2011 806 814
13. G.H. Mazurek, J. Jereb, A. Vernon Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection-United States, 2010 MMWR Recomm Rep 59 RR-5 2010 1 25
14. Canadian Tuberculosis Committee Updated recommendations on interferon gamma release assays for latent tuberculosis infection An Advisory Committee Statement (ACS) Can Commun Dis Rep 34 ACS-6 2008 1 13
15. National Institute for Health and Clinical Excellence Clinical diagnosis and management of tuberculosis, and measures for its prevention and control CG117 2011 National Institute for Health and Clinical Excellence London
16. British Thoracic Society Standards of Care Committee Guidelines for the prevention and management of Mycobacterium tuberculosis infection and disease in adult patients with chronic kidney disease Thorax 65 6 2010 557 570
17. Health Protection Agency Health Protection Agency Position Statement on the Use of Interferon Gamma Release Assay (IGRA) Tests for Tuberculosis (TB) 2007 Health Protection Agency London
18. Swiss Lung Association Tuberculosis in Switzerland 2011 Swiss Lung Association Berne
19. M. Pai, L.W. Riley, J.M. Colford Jr Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review Lancet Infect Dis 4 12 2004 761 776
20. M. Pai, A. Zwerling, D. Menzies Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update Ann Intern Med 149 3 2008 177 184
21. K.C. Chang, C.C. Leung Systematic review of interferon-gamma release assays in tuberculosis: focus on likelihood ratios Thorax 65 3 2010 271 276
22. J. Dinnes, J. Deeks, H. Kunst A systematic review of rapid diagnostic tests for the detection of tuberculosis infection Health Technol Assess 11 3 2007 1 196
23. P. Whiting, A.W.S. Rutjes, J.B. Reitsma, P.M.M. Bossuyt, J. Kleijnen The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews BMC Med Res Methodol 3 2003 25
24. A. Agresti An Introduction to Categorical Data Analysis 1996 Wiley New York, NY
25. World Health Organisation Global Tuberculosis Control 2010 WHO Geneva, Switzerland
26. J.A. Linquist, C.M. Rosaia, B. Riemer, K. Heckman, F. Alvarez Tuberculosis exposure of patients and staff in an outpatient hemodialysis unit Am J Infect Control 30 5 2002 307 310 (Pubitemid 34852416)
27. L. Hickstein, C. McPherson, D. Kwalick Tuberculosis transmission in a renal dialysis center-Nevada, 2003 MMWR Morb Mortal Wkly Rep 53 37 2004 873 875
28. T. Inoue, T. Nakamura, A. Katsuma The value of QuantiFERON TB-Gold in the diagnosis of tuberculosis among dialysis patients Nephrol Dial Transplant 24 7 2009 2252 2257
29. S.S.J. Lee, K.J. Chou, H.Y. Dou High prevalence of latent tuberculosis infection in dialysis patients using the interferon- release assay and tuberculin skin test Clin J Am Soc Nephrol 5 8 2010 1451 1457
30. Lee S, Chou KJ, Su IJ, et al. High prevalence of latent tuberculosis infection in end-stage renal disease patients on hemodialysis, using QuantiFERON-GOLD In-Tube Test and tuberculin skin test. Paper presented at: 49th Interscience Conference on Antimicrobial Chemotherapy. September 12-15, 2009; San Francisco, CA.
31. E.C. Seyhan, S. Sokucu, S. Altin Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection in hemodialysis patients Transplant Infect Dis 12 2 2010 98 105
32. S.H. Kim, S.O. Lee, I.A. Park Diagnostic usefulness of a T cell-based assay for latent tuberculosis infection in kidney transplant candidates before transplantation Transplant Infect Dis 12 2 2010 113 119
33. Kim S, Lee S, Park I, et al. A prospective longitudinal study of usefulness of a T cell-based assay for latent tuberculosis infection (LTBI) in renal transplant recipients. Paper presented at: 48th Meeting of the Infectious Diseases Society of America. October 21-24, 2010; Vacouver, BC.
34. W.K. Chung, Z.L. Zheng, H.-S. Kim Serial testing of interferon-gamma- release assays for the diagnosis of latent tuberculosis in hemodialysis patients J Infect 61 2 2010 144 149
35. P.-A. Triverio, P.-O. Bridevaux, P. Roux-Lombard Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients Nephrol Dial Transplant 24 6 2009 1952 1956
36. S.S.J. Lee, K.J. Chou, I.J. Su High prevalence of latent tuberculosis infection in patients in end-stage renal disease on hemodialysis: comparison of QuantiFERON-TB GOLD, ELISPOT, and tuberculin skin test Infection 37 2 2009 96 102
37. Lee S, Ni Y, Huang T, et al. QuantiFERON-TB GOLD for diagnosis of latent tuberculosis infection in patients with end-stage renal disease in Taiwan. Paper presented at: 46th Interscience Conference on Antimicrobial Chemotherapy. September 27-30, 2006; San Francisco, CA.
38. T. Eleftheriadis, P. Tsiaga, G. Antoniadi The value of serum antilipoarabinomannan antibody detection in the diagnosis of latent tuberculosis in hemodialysis patients Am J Kidney Dis 46 4 2005 706 712 (Pubitemid 41383949)
39. M. Yanai, Y. Uehara, M. Takeuchi Evaluation of serological diagnosis tests for tuberculosis in hemodialysis patients Ther Apher Dial 10 3 2006 278 281 (Pubitemid 43979300)
40. A. Wauters, W.E. Peetermans, P. Van den Brande The value of tuberculin skin testing in haemodialysis patients Nephrol Dial Transplant 19 2 2004 433 438 (Pubitemid 38195995)
41. M.S.R. Shankar, A.N. Aravindan, P.M. Sohal The prevalence of tuberculin sensitivity and anergy in chronic renal failure in an endemic area: tuberculin test and the risk of post-transplant tuberculosis Nephrol Dial Transplant 20 12 2005 2720 2724 (Pubitemid 41672271)
42. H.C. Fang, K.J. Chou, C.L. Chen Tuberculin skin test and anergy in dialysis patients of a tuberculosis-endemic area Nephron 91 4 2002 682 687
43. A. Yildiz, V. Akkaya, S. Turk, M.S. Sever, E. Ark, P. Yildiz Tuberculin responsiveness in hemodialysis patients Chest 114 3 1998 947 948
44. A. Yildiz, M.S. Sever, P. Yildiz Tuberculin (PPD) reactivity in hemodiaylsis patients (HDp) Nephrol DialTransplant 12 9 1997 A148
45. G. Ates, T. Yildiz, R. Danis Incidence of tuberculosis disease and latent tuberculosis infection in patients with end stage renal disease in an endemic region Ren Fail 32 1 2010 91 95
46. G. Ates, T. Ozekinci, A. Yildiz, R. Danis Comparison of interferon-gamma release assay versus tuberculin skin test for latent tuberculosis screening in hemodialysis patients Biotechnol Biotechnol Equip 23 2 2009 1242 1246
47. M.A. Habesoglu, D. Torun, Y.Z. Demiroglu Value of the tuberculin skin test in screening for tuberculosis in dialysis patients Transplant Proc 39 4 2007 883 886 (Pubitemid 46764836)
48. H. Taskapan, O. Oymak, C. Utas Tuberculin and anergy testing in CAPD patients Perit Dial Int 20 6 2000 807 809
49. E. Dogan, R. Erkoc, H. Sayarlioglu, K. Uzun Tuberculin skin test results and the booster phenomenon in two-step tuberculin skin testing in hemodialysis patients Ren Fail 27 4 2005 425 428 (Pubitemid 41001403)
50. K. Cengiz, A. Seker Boosted tuberculin skin testing in hemodialysis patients Am J Infect Control 34 6 2006 383 387 (Pubitemid 44108328)
51. K.F. Woeltje, A. Mathew, M. Rothstein, S. Seiler, V.J. Fraser Tuberculosis infection and anergy in hemodialysis patients Am J Kidney Dis 31 5 1998 848 852 (Pubitemid 28234638)
52. M. Smirnoff, C. Patt, B. Seckler, J.J. Adler Tuberculin and anergy skin testing of patients receiving long-term hemodialysis Chest 113 1 1998 25 27 (Pubitemid 28044919)
53. R.D. Poduval, M.S. Hammes Tuberculosis screening in dialysis patients-is the tuberculin test effective? Clin Nephrol 59 6 2003 436 440 (Pubitemid 36722324)
54. U. Sester, H. Junker, T. Hodapp Improved efficiency in detecting cellular immunity towards M. tuberculosis in patients receiving immunosuppressive drug therapy Nephrol Dial Transplant 21 11 2006 3258 3268 (Pubitemid 44567103)
55. U. Sester, H. Wilkens, K. Van Bentum Impaired detection of Mycobacterium tuberculosis immunity in patients using high levels of immunosuppressive drugs Eur Respir J 34 3 2009 702 710
56. L. Passalent, K. Khan, R. Richardson, J. Wang, H. Dedier, M. Gardam Detecting latent tuberculosis infection in hemodialysis patients: a head-to-head comparison of the T-SPOT.TB test, tuberculin skin test, and an expert physician panel Clin J Am Soc Nephrol 2 1 2007 68 73
57. K.L. Winthrop, M. Nyendak, H. Calvet Interferon-gamma release assays for diagnosing Mycobacterium tuberculosis infection in renal dialysis patients Clin J Am Soc Nephrol 3 5 2008 1357 1363
58. G. Kantarci, H. Altinoz, S. Sahin, G. Manga, G. Tasan Tuberculin positivity: a serious problem before transplantation in Turkey Transplant Proc 38 2 2006 646 648
59. O. Aydogan, A. Gurgun, O.K. Basoglu [Tuberculin skin test reactivity in patients with chronic renal failure] [in Turkish] Tuberk Toraks 57 3 2009 268 276
60. O.K. Basoglu, A. Atasever, C. Gunduz Telli [T-lymphocyte subgroups and tuberculin skin test reactivity in patients with chronic renal failure] Tuberk Toraks 54 1 2006 5 10 (Pubitemid 43962546)
61. Mycobacterium tuberculosis Am J Transplant 4 suppl 10 2004 37 41
62. J.S. Rothel, A.J. Radford Comparison of tuberculosis tests: finding truth or confirming prejudice? Clin Infect Dis 36 9 2003 1206 1207 author reply 1209-1210 (Pubitemid 36549649)
63. A.A. Pathan, K.A. Wilkinson, P. Klenerman Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment J Immunol 167 9 2001 5217 5225 (Pubitemid 33009758)
64. H. Shams, B. Wizel, S.E. Weis, B. Samten, P.F. Barnes Contribution of CD8(+) T cells to gamma interferon production in human tuberculosis Infect Immun 69 5 2001 3497 3501 (Pubitemid 32332257)
65. J.J. Rooney Jr, J.A. Crocco, S. Kramer, H.A. Lyons Further observations on tuberculin reactions in active tuberculosis Am J Med 60 4 1976 517 522
66. C.S. Hirsch, Z. Toossi, C. Othieno Depressed T-cell interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy J Infect Dis 180 6 1999 2069 2073
67. A.I. Christopoulos, A.A. Diamantopoulos, P.A. Dimopoulos, D.S. Goumenos, G.A. Barbalias Risk factors for tuberculosis in dialysis patients: a prospective multi-center clinical trial BMC Nephrol 10 2009 36